Cargando…
DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice
Considering high prevalence of non-alcoholic fatty liver diseases (NAFLD) in patients with inflammatory bowel disease (IBD), this study aimed to elucidate molecular mechanisms for how intestinal inflammatory conditions are causally linked to hepatic steatosis and dyslipidemia. Both younger and older...
Autores principales: | Kwon, Jeonghyeon, Lee, Chungho, Heo, Sungbaek, Kim, Bobae, Hyun, Chang-Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935975/ https://www.ncbi.nlm.nih.gov/pubmed/33674694 http://dx.doi.org/10.1038/s41598-021-84761-1 |
Ejemplares similares
-
Disturbance of lipid metabolism in germ-free mice transplanted with gut microbiota of DSS-induced colitis mice
por: Lee, Chungho, et al.
Publicado: (2023) -
Comprehensive amelioration of high-fat diet-induced metabolic dysfunctions through activation of the PGC-1α pathway by probiotics treatment in mice
por: Kwon, Jeonghyeon, et al.
Publicado: (2020) -
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice
por: Jall, Sigrid, et al.
Publicado: (2017) -
Late-Onset Lipid Storage Myopathy with Fatal Hepatosteatosis
por: Yavuz, Arda, et al.
Publicado: (2020) -
Loss of Fas apoptosis inhibitory molecule leads to spontaneous obesity and hepatosteatosis
por: Huo, J, et al.
Publicado: (2016)